Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

[New definition of metabolic syndrome: does it have the same cardiovascular risk?].

Rodilla E, González C, Costa JA, Pascual JM.

Rev Clin Esp. 2007 Feb;207(2):69-74. Spanish.

PMID:
17397565
2.
3.

[Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain].

Rodríguez Bernardino A, García Polavieja P, Reviriego Fernández J, Serrano Ríos M.

Endocrinol Nutr. 2010 Feb;57(2):60-70. doi: 10.1016/j.endonu.2009.12.002. Epub 2010 Feb 12. Spanish.

PMID:
20153706
4.
5.

Relation of albumin/creatinine ratio to C-reactive protein and to the metabolic syndrome.

Messerli AW, Seshadri N, Pearce GL, Sachar R, Hoogwerf BJ, Sprecher DL.

Am J Cardiol. 2003 Sep 1;92(5):610-2.

PMID:
12943889
6.

[Comparison of the definitions of the metabolic syndrome according to ATP III and IDF].

Sarmiento Méndez LM, Roca-Cusachs Coll A, Arroyo Díaz JA, Benet Gustà MT, Solé Villa MJ, Franco Peral M.

Rev Clin Esp. 2008 Jul-Aug;208(7):333-8. Spanish.

PMID:
18625179
7.

[Role of atherogenic dyslipidemia in the development of metabolic syndrome].

Real JT, Romero P, Martínez Hervas S, Pedro T, Carmena R, Ascaso JF.

Med Clin (Barc). 2006 Sep 9;127(9):321-4. Spanish.

PMID:
16987450
8.

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.

Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G, Keech AC; FIELD Study Investigators.

Cardiovasc Diabetol. 2011 Nov 21;10:102. doi: 10.1186/1475-2840-10-102.

9.

Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.

Ucar E, Huzmeli C, Guven O, Savas N, Gullu M, Asilyoruk S, Kuvandik C, Temizkan A, Kuvandik G.

Ren Fail. 2009;31(3):221-8. doi: 10.1080/08860220802669883.

PMID:
19288328
10.

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A; GREECE-METS Collaborative Group.

Int J Cardiol. 2007 Apr 25;117(2):204-10. Epub 2006 Jul 18.

PMID:
16854482
11.
12.

[The prevalence of metabolic syndrome in middle-aged in Kaunas population].

Gustiene O, Slapikas R, Klumbiene J, Sakalauskiene G, Kubilius R, Bagdzeviciūte S, Zaliūnas R.

Medicina (Kaunas). 2005;41(10):867-76. Lithuanian.

13.

Relationships Between Metabolic Syndrome, Microalbuminuria, and C-Reactive Protein in Turkish Kidney Transplant Recipients.

Sipahioglu MH, Unal A, Yazgac H, Tunca O, Arikan T, Kocyigit I, Tokgoz B, Oymak O.

Transplant Proc. 2015 Jun;47(5):1408-12. doi: 10.1016/j.transproceed.2015.04.037.

PMID:
26093730
14.

Prevalence of metabolic syndrome in an elderly community: comparison between three diagnostic methods.

Rigo JC, Vieira JL, Dalacorte RR, Reichert CL.

Arq Bras Cardiol. 2009 Aug;93(2):85-91.

15.

Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.

Boronat M, Saavedra P, Varillas VF, Wagner AM, López-Plasencia Y, Alberiche MP, Nóvoa FJ.

Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):417-22. doi: 10.1016/j.numecd.2008.07.010. Epub 2008 Sep 25.

PMID:
18819785
16.

Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.

Koutsovasilis A, Protopsaltis J, Triposkiadis F, Kokkoris S, Milionis HJ, Zairis MN, Skoularigis J, Koukoulis G, Korantzopoulos P, Melidonis A, Foussas SG.

Intern Med. 2009;48(4):179-87. Epub 2009 Feb 16.

17.

[The metabolic syndrome: marker of cardiovascular risk in hypertensive patients? The importance of definition].

Marboeuf P, Gras M, Rosey G, Fontaine P, Mounier-Vehier C.

Arch Mal Coeur Vaiss. 2007 Aug;100(8):642-8. French.

PMID:
17928768
18.

Prevalence of metabolic syndrome in elderly and agreement among four diagnostic criteria.

Saad MA, Cardoso GP, Martins Wde A, Velarde LG, Cruz Filho RA.

Arq Bras Cardiol. 2014 Mar;102(3):263-9. Epub 2014 Feb 10. English, Portuguese.

19.

Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men.

Lin MS, Shih SR, Li HY, Chuang LM, Chang TC, Wei JN, Shieh GJ, Chien YF, Hua CH, Hwang JJ.

Diabetes Res Clin Pract. 2007 Aug;77(2):286-92. Epub 2007 Jan 16.

PMID:
17234298
20.

The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.

Blackburn P, Lemieux I, Alméras N, Bergeron J, Côté M, Tremblay A, Lamarche B, Després JP.

Metabolism. 2009 Aug;58(8):1123-30. doi: 10.1016/j.metabol.2009.03.012. Epub 2009 Jun 18.

PMID:
19481769

Supplemental Content

Support Center